BDBM242509 US9422235, 92::US9422235, 96

SMILES FC(F)(F)c1cc(NC2CCCCC2)ccc1S(=O)(=O)NCC1CC1

InChI Key InChIKey=VVDBGAGVTDFSCQ-UHFFFAOYSA-N

Data  4 KI  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 242509   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242509(US9422235, 92 | US9422235, 96)
Affinity DataKi:  79nM ΔG°:  -9.84kcal/mole IC50:  135nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242509(US9422235, 92 | US9422235, 96)
Affinity DataKi:  80nM ΔG°:  -9.84kcal/mole IC50:  143nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242509(US9422235, 92 | US9422235, 96)
Affinity DataKi:  318nM ΔG°:  -9.01kcal/mole IC50:  547nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242509(US9422235, 92 | US9422235, 96)
Affinity DataKi:  3.00E+3nM ΔG°:  -7.66kcal/mole IC50:  6.00E+3nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent